09-08-2025
Leerink Partners Reaffirms Their Hold Rating on Clover Health Investments (CLOV)
In a report released today, Whit Mayo from Leerink Partners maintained a Hold rating on Clover Health Investments, with a price target of $2.50. The company's shares closed today at $2.18.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mayo covers the Healthcare sector, focusing on stocks such as Tenet Healthcare, Universal Health, and Ardent Health Partners, Inc.. According to TipRanks, Mayo has an average return of 0.3% and a 45.48% success rate on recommended stocks.
In addition to Leerink Partners, Clover Health Investments also received a Hold from UBS's Jonathan Yong in a report issued on August 6. However, yesterday, Canaccord Genuity maintained a Buy rating on Clover Health Investments (NASDAQ: CLOV).
